Use of extrapolation common in FDA new drug approvals

Scientists make new discoveries in the origin and ID of pancreatic endocrine cells
19 April 2022
Transgender, gender-questioning teens have worse health outcomes
19 April 2022

Use of extrapolation common in FDA new drug approvals

Extrapolation from pivotal trial data to broader U.S. Food and Drug Administration (FDA)-approved indications is common, according to a study published online April 19 in JAMA Network Open.

Comments are closed.